Salarius Pharmaceuticals, Inc., is a biotechnology company incorporated in Delaware on February 26, 2014, and its operations are primarily located in Boston, Massachusetts. The company is developing innovative and proprietary treatments for nighttime leg cramps and spasms associated with severe neuromuscular conditions. The company believes that primary sensory neurons that activate certain receptors reduce repetitive firing, or overexcitement, α-motor neurons, thereby preventing or reducing the frequency and intensity of muscle spasms and twitching. The company also believes that it is the only company to develop a product based on this muscle spasm and spasm inhibition mechanism. 

SLRX

SLRX Profile